Blood-brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions

被引:698
作者
Persidsky, Yuri [1 ,2 ,3 ]
Ramirez, Servio H. [1 ,2 ]
Haorah, James [1 ,2 ]
Kanmogne, Georgette D. [1 ,2 ]
机构
[1] Univ Nebraska Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
[3] 985215 Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
关键词
blood-brain barrier; leukocyte migration; tight junctions; multidrug resistance proteins; neurovascular unit;
D O I
10.1007/s11481-006-9025-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The blood-brain barrier (BBB) is the specialized system of brain microvascular endothelial cells (BMVEC) that shields the brain from toxic substances in the blood, supplies brain tissues with nutrients, and filters harmful compounds from the brain back to the bloodstream. The close interaction between BMVEC and other components of the neurovascular unit (astrocytes, pericytes, neurons, and basement membrane) ensures proper function of the central nervous system (CNS). Transport across the BBB is strictly limited through both physical (tight junctions) and metabolic barriers (enzymes, diverse transport systems). A functional polarity exists between the luminal and abluminal membrane surfaces of the BMVEC. As a result of restricted permeability, the BBB is a limiting factor for the delivery of therapeutic agents into the CNS. BBB breakdown or alterations in transport systems play an important role in the pathogenesis of many CNS diseases (HIV-1 encephalitis, Alzheimer's disease, ischemia, tumors, multiple sclerosis, and Parkinson's disease). Proinflammatory substances and specific disease-associated proteins often mediate such BBB dysfunction. Despite seemingly diverse underlying causes of BBB dysfunction, common intracellular pathways emerge for the regulation of the BBB structural and functional integrity. Better understanding of tight junction regulation and factors affecting transport systems will allow the development of therapeutics to improve the BBB function in health and disease.
引用
收藏
页码:223 / 236
页数:14
相关论文
共 174 条
[1]   Astrocyte-endothelial interactions at the blood-brain barrier [J].
Abbott, NJ ;
Rönnbäck, L ;
Hansson, E .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) :41-53
[2]   Dynamics of CNS barriers: Evolution, differentiation, and modulation [J].
Abbott, NJ .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2005, 25 (01) :5-23
[3]   Astrocyte-endothelial interactions and blood-brain barrier permeability [J].
Abbott, NJ .
JOURNAL OF ANATOMY, 2002, 200 (06) :629-638
[4]   Inflammatory mediators and modulation of blood-brain barrier permeability [J].
Abbott, NJ .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2000, 20 (02) :131-147
[5]  
Adamson P, 1999, J IMMUNOL, V162, P2964
[6]   The role of cadherin endocytosis in endothelial barrier regulation: Involvement of protein kinase C and actin-cadherin interactions [J].
Alexander, JS ;
Jackson, SA ;
Chaney, E ;
Kevil, CG ;
Haselton, FR .
INFLAMMATION, 1998, 22 (04) :419-433
[7]   Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow [J].
Allport, JR ;
Muller, WA ;
Luscinskas, FW .
JOURNAL OF CELL BIOLOGY, 2000, 148 (01) :203-216
[8]   Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells [J].
András, IE ;
Pu, H ;
Tian, J ;
Deli, MA ;
Nath, A ;
Hennig, B ;
Toborek, M .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2005, 25 (09) :1159-1170
[9]   Protein kinase C regulates the phosphorylation and cellular localization of occludin [J].
Andreeva, AY ;
Krause, E ;
Müller, EC ;
Blasig, IE ;
Utepbergenov, DI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) :38480-38486
[10]   Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin [J].
Antonetti, DA ;
Wolpert, EB ;
DeMaio, L ;
Harhaj, NS ;
Scaduto, RC .
JOURNAL OF NEUROCHEMISTRY, 2002, 80 (04) :667-677